Zhao, Shengyan
Deng, Han
Lu, Ying
Tao, Yiran
Li, David
Jiang, Xiaohua
Wei, Xian
Chen, Xiaofeng
Ma, Fanxin
Wang, Yuxi
Gou, Lantu
Yang, Jinliang
Funding for this research was provided by:
the CAMS Innovation Fund for Medical Sciences (2021-I2M-5-075, 2021-I2M-5-075, 2021-I2M-5-075, 2021-I2M-5-075, 2021-I2M-5-075, 2021-I2M-5-075, 2021-I2M-5-075, 2021-I2M-5-075, 2021-I2M-5-075, 2021-I2M-5-075)
the National Major Scientifc and Technological Special Project for Signifcant New Drugs Development (2018ZX09201018, 2017ZX09302010, 2018ZX09201018, 2017ZX09302010, 2018ZX09201018, 2017ZX09302010, 2018ZX09201018, 2017ZX09302010, 2018ZX09201018, 2017ZX09302010, 2018ZX09201018, 2017ZX09302010, 2018ZX09201018, 2017ZX09302010, 2018ZX09201018, 2017ZX09302010, 2018ZX09201018, 2017ZX09302010, 2018ZX09201018, 2017ZX09302010)
Article History
Received: 7 May 2024
Accepted: 25 June 2024
First Online: 22 August 2024
Declarations
:
: All animal experiments were approved by the State Key Laboratory of Biotherapy, Sichuan University of experimental animal ethics committee, the experiments were carried out in accordance with approved guidelines (20220531059).
: All the authors have read and approved the paper for publication.
: The authors declare no competing interests.